http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103741467-B

Outgoing Links

Predicate Object
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D06M101-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D06M101-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D06M13-328
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D06M13-188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D06M15-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D01F8-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D06M13-123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D01F8-10
filingDate 2013-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103741467-B
titleOfInvention Be applied to the preparation method that target catches the hyaluronic acid functionalized nano-fiber of cancer cell
abstract The present invention relates to and be a kind ofly applied to the preparation method that target catches the hyaluronic acid functionalized nano-fiber of cancer cell, comprise: (1) take water as solvent configuration PVA/PEI spinning solution, then electrostatic spinning is carried out, after drying in containing the drier of glutaraldehyde solution vacuum crosslinking Treatment, obtain the PVA/PEI nanofiber that water stability is good; (2) hyaluronic acid activated is joined in the good PVA/PEI nanofiber of water stability, shaking table is obtained by reacting the Static Spinning PVA/PEI nanofiber of hyaluronic acid functional modification; Add triethylamine again and the amino of PEI/PVA nano fibrous membrane surface residual is all carried out acetylation process by acetic anhydride, finally wash, dry.Low in raw material price of the present invention, preparation technology are simple, and the hyaluronic acid functionalization electrostatic spinning nano fiber of preparation has good pattern and structural stability, biocompatibility and blood compatibility, has a extensive future.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105327357-B
priorityDate 2013-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448844975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425356381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6432052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422071869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18381240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453759058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546193
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22629

Total number of triples: 46.